Džeina Mežale

Medicine & Life Sciences

1. Latvia 100%
2. Human immunodeficiency virus 1 reverse transcriptase 88%
3. Integrases 84%
4. HIV-1 84%
5. Growth 74%
6. Adenocarcinoma 70%
7. Mammography 68%
8. Cellular Immunity 62%
9. Early Detection of Cancer 61%
10. Immunization 54%
11. Reactive Oxygen Species 51%
12. HIV 50%
13. Neoplasm Metastasis 48%
14. Up-Regulation 46%
15. Epithelial Cells 46%
16. Neoplasms 43%
17. Breast Neoplasms 41%
18. Inbred BALB C Mouse 37%
19. Human Mammary Glands 27%
20. Pharmaceutical Preparations 26%
21. Clone Cells 25%
22. Human Immunodeficiency Virus Proteins 25%
23. Lipid Peroxidation 23%
24. Ribonuclease H 23%
25. rat Tert protein 20%
26. Cell Movement 20%
27. Carcinogenesis 19%
28. Kaposi's Sarcoma 19%
29. Mutation 18%
30. DNA 17%
31. Nucleosides 17%
32. Vimentin 16%
33. Non-Hodgkin's Lymphoma 15%
34. Uterine Cervical Neoplasms 14%
35. Drug Resistance 14%
36. Wound Healing 14%
37. Acquired Immunodeficiency Syndrome 13%
38. Virus Diseases 11%
39. Lentivirus 10%
40. RNA-Directed DNA Polymerase 10%
41. Telomerase 10%
42. T-Lymphocytes 9%
43. Human Herpesvirus 4 9%
44. Coinfection 8%
45. Formaldehyde 8%
46. Paraffin 8%
47. Raltegravir Potassium 7%
48. Oxidative Stress 7%
49. Incidence 7%
50. Microscopy 7%